| Literature DB >> 29342302 |
Norifumi Mizuno1, Haruna Takahashi2, Jiro Kawamori1, Naoki Nakamura1,3, Mami Ogita1,4, Shogo Hatanaka1,5, Ryouhei Yamauchi1, Masatsugu Hariu5, Kenji Sekiguchi1,6.
Abstract
Some patients undergoing breast reconstruction require post-mastectomy radiation therapy, but the metallic ports used in temporary tissue expanders attenuate the X-rays. In this study, we evaluated by the film method, the attenuation of 4 MV and 6 MV X-rays after passing through a metallic port, with the aim of identifying a useful method for determining the appropriate density to use in the radiation treatment planning system (RTPS), taking into account the distance between the metallic port and the targets. Radiochromic film was used to measure depth doses after the X-rays passed through the metallic port. The physical density allotted to the metal port portion was varied on the RTPS within the range 1-16 g/cm3, and the physical density values were calculated that best reproduced the depth-dose distribution extrapolated from the film method. When the metallic port was orientated perpendicularly, the attenuation of the X-rays peaked at ~7% at both 4 MV and 6 MV. In the parallel orientation, the X-rays were attenuated by up to ~40% at 4 MV and by up to ~30% at 6 MV. We estimated the optimum physical density to be 9.8 g/cm3, which yielded the best fit with the actual measurements. We demonstrated the most likely range for the target depth from the CT images of actual patients and, within this range, we identified the optimum physical density at which the measured and calculated values were most consistent with each other.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29342302 PMCID: PMC5951076 DOI: 10.1093/jrr/rrx085
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Fig. 1.Geometry and the two orientations of the metallic port used in the phantom study.
Fig. 2.Example of the two measured distances between the metallic port and the chest wall. The longer distance is defined by the path taken by the beam passing through the boundary of the metallic port to the skin, and the shorter one is defined as the distance from the boundary of the metallic port to the boundary of the temporary tissue expander.
Fig. 3.Example of the clinical target volume for evaluation (CTVeval, marked in blue). The CTVeval included the area to the pleura or the ribs under the TTE.
Fig. 4.Changes in the depth–dose distribution with and without the metallic port. (a) 4 MV. (b) 6 MV.
PDD10 and differences in the dose at the peak depth and at depths of 5, 10 and 15 cm without the metallic port and with the port in the two orientations
| Parameter | 4 MV without | 4 MV down | 4 MV up | 6 MV without | 6 MV down | 6 MV up |
|---|---|---|---|---|---|---|
| Depth of dose maximum | – | −5.0% | −38.8% | – | −4.4% | −30.2% |
| Depth, 5 cm | – | −6.9% | −34.6% | – | −3.8% | −26.9% |
| Depth, 10 cm | – | −2.7% | −29.7% | – | −3.1% | −25.6% |
| Depth, 15 cm | – | −1.4% | −30.3% | – | −3.4% | −25.1% |
| PDD10 | 61.6 | 63.1 | 70.8 | 66.8 | 67.7 | 71.3 |
PDD10 = percentage of the depth dose at 10 cm, without = without the metallic port, down = with the port in the down-perpendicular orientation, up = with the port in the up-parallel orientation.
Fig. 5.Comparison of the measured and calculated values when different physical densities (PDs, g/cm3) were allotted to the metallic port. (a) 4 MV, down-perpendicular orientation. (b) 4 MV, up-parallel orientation. (c) 6 MV, down-perpendicular orientation. (d) 6 MV, up-parallel orientation.
Fig. 6.Example of the dose distribution in post-mastectomy radiation therapy with the metallic port assigned the optimum density value. (a) 4 MV (b) 6 MV.
Dose–volume parameters for CTVeval in OD plans against PD1 plans (n = 20)
| Parameter | 4 MV plans | 6 MV plans | |
|---|---|---|---|
| Dose volume | |||
| | −3.8 ± 2.0 cm3 [−0.2 to −7.7] | −3.6 ± 1.4 cm3 [−1.6 to −6.4] | 0.495 |
| | −3.0 ± 1.1 cm3 [−1.2 to −5.4] | −3.0 ± 0.9 cm3 [−1.9 to −4.8] | 0.879 |
| | −1.7 ± 0.6 cm3 [−0.8 to −3.5] | −1.7 ± 0.6 cm3 [−0.9 to −2.6] | 0.782 |
| | −0.3 ± 0.3 cm3 [−0.0 to −0.9] | −0.3 ± 0.2 cm3 [−0.0 to −0.9] | 0.610 |
| −8.2 ± 1.4 % [−6.2 to −11.1] | −4.6 ± 1.6 % [−1.3 to −7.8] | <0.001 | |
Values are presented as mean ± standard deviation [range]. CTVeval = clinical target volume for the evaluation, OD plans = plans based on the calculated optimum density, PD1 plans = plans with the metallic port assigned the physical density of 1 g/cm3, V = volume, Dmin = minimum dose.